These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 2013240

  • 1. Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.
    Yourassowsky E, Van der Linden MP, Crokaert F.
    Chemotherapy; 1991; 37(1):38-42. PubMed ID: 2013240
    [Abstract] [Full Text] [Related]

  • 2. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L, Biedenbach DJ, Jones RN.
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [Abstract] [Full Text] [Related]

  • 3. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
    Jorgensen JH, Maher LA, Howell AW.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):600-2. PubMed ID: 2039214
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial effect of meropenem and imipenem on Proteus mirabilis.
    Yourassowsky E, Van der Linden MP, Crokaert F.
    J Antimicrob Chemother; 1990 Aug; 26(2):185-92. PubMed ID: 2211455
    [Abstract] [Full Text] [Related]

  • 5. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
    Powell M, Seetulsingh P, Williams JD.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206
    [Abstract] [Full Text] [Related]

  • 6. [Selection of resistance mutants and bacteriostatic and bactericidal activity of meropenem and imipenem against Acinetobacter spp].
    Villar HE, Laurino G, Arena MF, Hoffman M.
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):140-3. PubMed ID: 9235053
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae.
    Cerami AT, Shungu DL.
    Antimicrob Agents Chemother; 1986 Jul; 30(1):179-80. PubMed ID: 3489437
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa.
    White R, Friedrich L, Burgess D, Warkentin D, Bosso J.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):904-8. PubMed ID: 8849249
    [Abstract] [Full Text] [Related]

  • 9. In-vitro activity of meropenem against Neisseria gonorrhoeae, Haemophilus influenzae and H. ducreyi from Canada and Kenya.
    Slaney L, Chubb H, Mohammed Z, Ronald A.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():183-6. PubMed ID: 2509415
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro killing activity of meropenem versus imipenem against multiresistant nosocomial Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Grecka P, Giamarellou H.
    J Chemother; 1995 Jun; 7(3):179-83. PubMed ID: 7562010
    [Abstract] [Full Text] [Related]

  • 11. [Bactericidal activity and capacity for selection of mutants resistant to imipenmen and meropenem in strains of Proteus, Morganella and Providencia].
    Villar HE, Longo L, Arena MF, Laurino G, Hoffman M.
    Enferm Infecc Microbiol Clin; 1998 Jun; 16(6):261-4. PubMed ID: 9763741
    [Abstract] [Full Text] [Related]

  • 12. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H, Harabe ET, Sumita Y, Okuda T, Fukasawa M.
    Chemotherapy; 1992 Jun; 38(4):218-24. PubMed ID: 1473360
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain.
    Kanazawa K, Nouda H, Sunagawa M.
    J Antibiot (Tokyo); 1997 Feb; 50(2):162-8. PubMed ID: 9099227
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
    Visser MR, Hoepelman IM, Beumer H, Rozenberg-Arska M, Verhoef J.
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1061-4. PubMed ID: 2695328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group.
    García-Rodriguez JA, García Sánchez JE, Trujillano I, Sánchez de San Lorenzo A.
    J Antimicrob Chemother; 1991 May; 27(5):599-606. PubMed ID: 1885418
    [Abstract] [Full Text] [Related]

  • 18. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [Abstract] [Full Text] [Related]

  • 19. Bactericidal activity of meropenem against Pseudomonas aeruginosa.
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():169-74. PubMed ID: 2509414
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.